A detailed history of Janney Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janney Capital Management LLC holds 45,664 shares of BMY stock, worth $2.57 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
45,664
Previous 44,831 1.86%
Holding current value
$2.57 Million
Previous $1.86 Million 26.91%
% of portfolio
0.16%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $33,036 - $43,107
833 Added 1.86%
45,664 $2.36 Million
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $110,365 - $145,298
-2,742 Reduced 5.76%
44,831 $1.86 Million
Q1 2024

May 01, 2024

SELL
$47.98 - $54.4 $51,962 - $58,915
-1,083 Reduced 2.23%
47,573 $2.58 Million
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $279,923 - $334,025
-5,774 Reduced 10.61%
48,656 $2.5 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $183,163 - $204,805
3,164 Added 6.17%
54,430 $3.16 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $203,680 - $226,155
3,197 Added 6.65%
51,266 $3.28 Million
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $609,525 - $691,340
9,276 Added 23.91%
48,069 $3.33 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $342,605 - $405,693
5,003 Added 14.81%
38,793 $2.79 Million
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $388 - $229,674
2,989 Added 9.7%
33,790 $2.4 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $139,793 - $153,961
1,925 Added 6.67%
30,801 $2.37 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $204,236 - $244,897
3,322 Added 13.0%
28,876 $2.11 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $13,085 - $15,254
-244 Reduced 0.95%
25,554 $1.59 Million
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $70,826 - $82,964
-1,197 Reduced 4.43%
25,798 $1.53 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $28,788 - $31,350
465 Added 1.75%
26,995 $1.8 Million
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $8.07 Million - $9.07 Million
-135,949 Reduced 83.67%
26,530 $1.68 Million
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $143,772 - $162,920
-2,490 Reduced 1.51%
162,479 $10.1 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $266,590 - $295,416
-4,642 Reduced 2.74%
164,969 $9.95 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $102,732 - $120,104
-1,874 Reduced 1.09%
169,611 $9.97 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $241,976 - $351,647
-5,215 Reduced 2.95%
171,485 $9.56 Million
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $7.56 Million - $9.86 Million
153,678 Added 667.53%
176,700 $11.3 Million
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $261,153 - $309,635
6,106 Added 36.1%
23,022 $1.17 Million
Q2 2019

Jul 29, 2019

BUY
$44.62 - $49.34 $52,606 - $58,171
1,179 Added 7.49%
16,916 $767,000
Q1 2019

Apr 30, 2019

BUY
$45.12 - $53.8 $12,182 - $14,526
270 Added 1.75%
15,737 $751,000
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $16,627 - $21,561
-341 Reduced 2.16%
15,467 $804,000
Q3 2018

Jan 04, 2019

SELL
$55.19 - $62.25 $31.2 Million - $35.2 Million
-564,862 Reduced 97.28%
15,808 $981,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $31.2 Million - $35.2 Million
564,978 Added 3600.42%
580,670 $0
Q2 2018

Jul 24, 2018

BUY
$50.53 - $62.98 $2,779 - $3,463
55 Added 0.35%
15,692 $868,000
Q1 2018

Apr 19, 2018

BUY
$59.92 - $68.98 $13,122 - $15,106
219 Added 1.42%
15,637 $989,000
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $8,631 - $9,410
-144 Reduced 0.93%
15,418 $944,000
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $859,489 - $991,921
15,562
15,562 $991,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Janney Capital Management LLC Portfolio

Follow Janney Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.